NEW YORK, Feb. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Nextracker Inc. (NASDAQ: NXT) between February 1, 2024 and August 1, 2024, both dates inclusive (the “Class Period”), of the important February 25, 2025…
Month: February 2025
Court approves plan to equitize over 85% of the Company’s debt and establish a healthy, robust capital structure Accuride expects to emerge from Chapter 11 in the coming weeks as a North American wheel company, well-positioned for long-term growth LIVONIA, Mich., Feb. 12, 2025…
CHANDLER, Ariz., Feb. 12, 2025 /PRNewswire/ — Embark Behavioral Health, a leader in youth and young adult mental health care, is reaffirming its commitment to creating joy and healing generations. Under the leadership of Scott Filion, CEO, and Dr. Sharnell Myles, Psy.D., Chief Clinical…
This news release contains forward-looking statements. For a description of the related risk factors and assumptions, please see the section entitled “Caution Concerning Forward-Looking Statements” later in this news release. MONTRÉAL, Feb. 12, 2025 /PRNewswire/ – Bell Canada (Bell) today…
ALPHARETTA, Ga., Feb. 12, 2025 /PRNewswire/ — Chroma Early Learning Academy, a leading provider of high-quality early childhood education, is proud to announce the opening of its 12th location in the Metro Atlanta area at 200 River Green Avenue, Canton, GA. This expansion supports…
NEW YORK, Feb. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Innovative Industrial Properties, Inc. (NYSE: IIPR) between February 27, 2024 and December 19, 2024, both dates inclusive (the “Class Period”), of the…
NEW YORK, Feb. 12, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025 lead…
Highlights: Ongoing clinical trial of SurVaxM in glioblastoma [SURVIVE] has successfully progressed following an interim analysis of trial data The clinical trial is designed to evaluate the safety, efficacy, and overall benefit of SurVaxM in patients with newly diagnosed glioblastoma who…
LG Chem has launched prototype production of 100% bio-acrylic acid, which has received USDA Certified Biobased Product (BIOPREFERRED®) label. The product is derived from 3HP made through a microbial fermentation process, offering the same properties as conventional acrylic acid and…